Parainfluenza virus 3 (PIV3) is a respiratory virus associated with severe childhood illnesses, particularly bronchiolitis and pneumonia. It is also known as human parainfluenza virus type 3 (HPIV3). PIV3 is a member of the Paramyxoviridae family, which includes other viruses such as measles, mumps, and respiratory syncytial virus (RSV). Despite its prevalence in the population, there is still much that is unknown about PIV3 and the diseases it causes. In this article, we will discuss the epidemiology, transmission, diagnosis, treatment, and prevention of PIV3.
PIV3 is a common virus, with an estimated 20-40% of all childhood respiratory illnesses being caused by it. It is most commonly seen in young children, with the highest incidence occurring in children between the ages of 6 months and 2 years. PIV3 is more common in the winter months, with peak activity occurring in December and January. It is also more common in certain geographical areas, such as the southeastern United States and in lower-income countries.
PIV3 is spread through contact with respiratory secretions, such as saliva, mucus, or nasal secretions. It is also spread through contact with surfaces or objects that have been contaminated with the virus. PIV3 is highly contagious and can be spread through coughing and sneezing.
The diagnosis of PIV3 is usually made based on clinical symptoms. However, laboratory tests can be used to confirm the diagnosis. These tests include polymerase chain reaction (PCR) tests, virus isolation, and serology tests.
There is no specific treatment for PIV3. Treatment is mainly supportive, and may include oxygen therapy, hydration, and medications to reduce fever and relieve symptoms. In severe cases, hospitalization may be necessary.
The best way to prevent PIV3 is to practice good hygiene. This includes washing hands often with soap and water, avoiding contact with people who are sick, and avoiding sharing items such as cups and utensils. Vaccines are also available to prevent PIV3, but they are not routinely recommended.
Parainfluenza virus 3 is a common virus that is associated with severe childhood illnesses. It is spread through contact with respiratory secretions and contaminated objects. Diagnosis is usually based on clinical symptoms, but laboratory tests can be used to confirm the diagnosis. Treatment is mainly supportive, and prevention is best achieved through good hygiene practices. Vaccines are available, but are not routinely recommended.
1.
Glioblastoma treatment breakthrough shows promise
2.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
3.
Study suggests exercise could reduce breast cancer recurrence
4.
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus
5.
Daily physical activity, even at light intensities, linked to lower cancer risk
1.
Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer
2.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
3.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
4.
HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation